Abnormalities in calcium and phosphorus metabolism are common, and metabolic bone
disease develops often in patients with chronic renal failure (CRF). Effective clinical …

Hyperphosphataemia is prevalent among chronic renal failure and dialysis patients. It is
known to stimulate parathyroid hormone and suppress vitamin D3 production, thereby …

Background. The majority of patients with end-stage renal disease on dialysis are
hyperphosphataemic. Lanthanum carbonate has been shown to be a highly effective …

Background. In patients undergoing peritoneal dialysis (PD), low-calcium dialysate (LCD)
has been proposed as the first choice for a better control of renal osteodystrophy. Our aim …

The topic of this thesis is the use of the vitamin D analog, 1α (OH) D3, in prophylaxis and
treatment of secondary hyperparathyroidism in uremic patients treated with chronic dialysis …

Objective Previous studies have shown a decrease in serum magnesium (Mg) concentration
when continuous ambulatory peritoneal dialysis (CAPD) patients previously maintained on a …

Hypercalcemia is a common complication in continuous ambulatory peritoneal dialysis
(CAPD) patients treated with calcium-containing phosphate binders and using the standard …

Although calcium salts are widely prescribed as oral phosphate binders for dialysis patients,
their use is associated with a number of problems (Table 1). The most troublesome side …

Objective To examine the effect of a reduced calcium/magnesium dialysis fluid (1.25/0.25
mmol/L, respectively) on calcium and magnesium mass transfer in both 1.36% and 3.86 …

Adynamic bone is being found with increasing frequency in dialysis patients. Little is known
about its aetiology, and even less about its natural history. We found 10 cases of …